Sildenafil (Viagra) protective effects on neuroinflammation: The role of iNOS/NO system in an inflammatory demyelination model

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Raposo, Catarina ^a   Nunes, Ana Karolina De Santana ^a,b   Luna, Rayana Leal De Almeida ^a,b   Araújo, Shyrlene Meiry Da Rocha ^b   Da Cruz Höfling, Maria Alice ^a   Peixoto, Christina Alves ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CUPRIZONE; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; IBA 1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; MYELIN; NITRIC OXIDE; SILDENAFIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLIC GMP; GLUTATHIONE TRANSFERASE P1; NOS2 PROTEIN, MOUSE; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; FEEDBACK SYSTEM; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; NERVE CELL; TOXICITY; ARTICLE; DRUG EFFECT;

ANIMALS; CUPRIZONE; CYCLIC GMP; DEMYELINATING DISEASES; GLUTATHIONE S-TRANSFERASE PI; INFLAMMATION; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MYELIN SHEATH; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; SULFONES;

EID: 84881407529     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/321460     Document Type: Review

References (38)

1. Nathan C., Xie Q.-W., Nitric oxide synthases: roles, tolls, and controls. Cell 1994 78 6 915 918 2-s2.0-0028092958 10.1016/0092-8674(94)90266-6 (Pubitemid 24292319)
2. Nathan C., Xie Q.-W., Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry 1994 269 19 13725 13728 2-s2.0-0028270719 (Pubitemid 24191108)
3. Palmer A. C., Calder I. M., Hughes J. T., Spinal cord degeneration in divers. The Lancet 1987 2 8572 1365 1366 2-s2.0-0023520984 (Pubitemid 18007241)
4. Garthwaite G., Garthwaite J., Cyclic GMP and cell death in rat cerebellar slices. Neuroscience 1988 26 1 321 326 2-s2.0-0023816358
5. Knowles R. G., Palacios M., Palmer R. M., Moncada S., Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 1989 86 13 5159 5162 2-s2.0-0343046540 (Pubitemid 19182253)
6. Hibbs J. B. Jr., Taintor R. R., Vavrin Z., Rachlin E. M., Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochemical and Biophysical Research Communications 1988 157 1 87 94 2-s2.0-0024244657 (Pubitemid 19004828)
7. Stuehr D. J., Nathan C. F., Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Journal of Experimental Medicine 1989 169 5 1543 1555 2-s2.0-0024584020 (Pubitemid 19126814)
8. Esplugues J. V., NO as a signalling molecule in the nervous system. British Journal of Pharmacology 2002 135 5 1079 1095 2-s2.0-0036196417 (Pubitemid 34259107)
9. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F., Activation of microglial cells by β -amyloid protein and interferon- γ Nature 1995 374 6523 647 650 2-s2.0-0028953529
10. Prickaerts J., Van Staveren W. C. G., Şik A., Markerink-van Ittersum M., Niewöhner U., Van der Staay F. J., Blokland A., De Vente J., Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002 113 2 351 361 2-s2.0-0037067992 10.1016/S0306- 4522(02)00199-9 (Pubitemid 34786180)
11. McGeer E. G., McGeer P. L., The role of anti-inflammatory agents in Parkinson's disease. CNS Drugs 2007 21 10 789 797 2-s2.0-34548822734 10.2165/00023210-200721100-00001 (Pubitemid 47443301)
12. Rosenberg G. A., Neurological diseases in relation to the blood-brain barrier. Journal of Cerebral Blood Flow & Metabolism 2012 32 1139 1151
13. Willenborg D. O., Staykova M., Fordham S., O'Brien N., Linares D., The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 2007 191 1-2 16 25 2-s2.0-35848956116 10.1016/j.jneuroim.2007. 09.007 (Pubitemid 350060995)
14. Sahrbacher U. C., Lechner F., Eugster H. P., Frei K., Lassmann H., Fontana A., Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. European Journal of Immunology 1998 28 4 1332 1338 2-s2.0-0032041760
15. Arnett H. A., Hellendall R. P., Matsushima G. K., Suzuki K., Laubach V. E., Sherman P., Ting J. P.-Y., The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. Journal of Immunology 2002 168 1 427 433 2-s2.0-0036136329 (Pubitemid 34014145)
16. Bender A. T., Beavo J. A., Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochemistry International 2004 45 6 853 857 2-s2.0-4243121730 10.1016/j.neuint.2004.03.015 (Pubitemid 39108057)
17. Schlossmann J., Hofmann F., cGMP-dependent protein kinases in drug discovery. Drug Discovery Today 2005 10 9 627 634 2-s2.0-18944382189 10.1016/S1359-6446(05)03406-9 (Pubitemid 40704770)
18. Kipp M., Clarner T., Gingele S., Pott F., Amor S., van der Valk P., Beyer C., Brain lipid binding protein (FABP7) as modulator of astrocyte function. Physiological Research 2011 60 supplement 1 S49 S60 2-s2.0-84856617583
19. Palmeri A., Privitera L., Giunta S., Loreto C., Puzzo D., Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory. Behavioural Brain Research 2013 240 11 20
20. Zhang L., Yu W., Schroedter I., Kong J., Vrontakis M., Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced ms mouse model. PLoS ONE 2012 7 3, article e33901 2-s2.0-84858674829 10.1371/journal.pone.0033901
21. Pifarre P., Prado J., Baltrons M. A., Giralt M., Gabarro P., Feinstein D. L., Hidalgo J., Garcia A., Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Acta Neuropathologica 2011 121 4 499 508 2-s2.0-79954610434 10.1007/s00401-010-0795-6
22. Nunes A. K. S., Rapôso C., Luna R. L., Cruz-Höfling M. A., Peixoto C. A., Sildenafil (Viagra) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine 2012 60 540 551
23. Zhao L., Mason N. A., Strange J. W., Walker H., Wilkins M. R., Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation 2003 107 2 234 237 2-s2.0-0037458096 10.1161/01.CIR.0000050653.10758.6B (Pubitemid 36135217)
24. Saraiva K. L. A., Silva A. K., Wanderley M. I., De Araújo A. A., De Souza J. R., Peixoto C. A., Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion. International Journal of Experimental Pathology 2009 90 4 454 462 2-s2.0-68849086811 10.1111/j.1365-2613.2009.00660.x
25. Moharregh-Khiabani D., Blank A., Skripuletz T., Miller E., Kotsiari A., Gudi V., Stangel M., Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse. PLoS ONE 2010 5 7, article e11769 2-s2.0-77955478688 10.1371/journal.pone.0011769
26. Gao Z., Tsirka S. E., Animal Models of MS reveal multiple roles of microglia in disease pathogenesis. Neurology Research International 2011 2011 9 383087 10.1155/2011/383087
27. Silvestroff L., Bartucci S., Pasquini J., Franco P., Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination. Experimental Neurology 2012 235 1 357 367 2-s2.0-84859914779 10.1016/j.expneurol.2012.02.018
28. Riccitelli G., Rocca M. A., Pagani E., Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis 2012 18 7 1027 1037 10.1177/1352458512439239
29. Shields S. D., Cheng X., Gasser A., Saab C. Y., Tyrrell L., Eastman E. M., Iwata M., Zwinger P. J., Black J. A., Dib-Hajj S. D., Waxman S. G., A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis. Annals of Neurology 2012 71 2 186 194 2-s2.0-84857606247 10.1002/ana.22665
30. Bernardini C., Greco F., Zannoni A., Bacci M. L., Seren E., Forni M., Differential expression of nitric oxide synthases in porcine aortic endothelial cells during LPS-induced apoptosis. The Journal of Inflammation 2012 9 47
31. Chang W.-L., Chung C.-H., Wu Y.-C., Su M.-J., The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway. Nitric Oxide 2004 11 4 307 315 2-s2.0-10344254299 10.1016/j.niox.2004.10.004 (Pubitemid 39626584)
32. Pérez-Sala D., Cernuda-Morollón E., Díaz-Cazorla M., Rodríguez-Pascual F., Lamas S., Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. American Journal of Physiology 2001 280 466 473
33. Datta P. K., Dhupar S., Lianos E. A., Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis. Nephrology Dialysis Transplantation 2006 21 1 51 57 2-s2.0-30344445683 10.1093/ndt/gfi135 (Pubitemid 43057109)
34. Beg A. A., Baltimore D., An essential role for NF- B in preventing TNF- α -induced cell death. Science 1996 274 5288 782 784 2-s2.0-0029976817 10.1126/science.274.5288.782 (Pubitemid 26398258)
35. Chanthaphavong R. S., Loughran P. A., Lee T. Y., Scott M. J., Billiar T. R., A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α -converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes. Journal of Biological Chemistry 2012 287 35887 35898
36. Beg A. A., Baltimore D., An essential role for NF- B in preventing TNF- α -induced cell death. Science 1996 274 5288 782 784 2-s2.0-0029976817 10.1126/science.274.5288.782 (Pubitemid 26398258)
37. Bénardais K., Kotsiari A., Skuljec J., Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotoxicity Research 2013 24 2 244 250
38. Benjamins J. A., Nedelkoska L., Cyclic GMP-dependent pathways protect differentiated oligodendrocytes from multiple types of injury. Neurochemical Research 2007 32 2 321 329 2-s2.0-33846914456 10.1007/s11064-006-9187-7 (Pubitemid 46238878)